Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 143

1.

Induction of endocannabinoid levels in juvenile rat brain following developmental chlorpyrifos exposure.

Carr RL, Adams AL, Kepler DR, Ward AB, Ross MK.

Toxicol Sci. 2013 Sep;135(1):193-201. doi: 10.1093/toxsci/kft126. Epub 2013 Jun 12.

2.

Low level chlorpyrifos exposure increases anandamide accumulation in juvenile rat brain in the absence of brain cholinesterase inhibition.

Carr RL, Graves CA, Mangum LC, Nail CA, Ross MK.

Neurotoxicology. 2014 Jul;43:82-9. doi: 10.1016/j.neuro.2013.12.009. Epub 2013 Dec 25.

3.

Effect of developmental chlorpyrifos exposure, on endocannabinoid metabolizing enzymes, in the brain of juvenile rats.

Carr RL, Borazjani A, Ross MK.

Toxicol Sci. 2011 Jul;122(1):112-20. doi: 10.1093/toxsci/kfr081. Epub 2011 Apr 20.

4.

Decreased anxiety in juvenile rats following exposure to low levels of chlorpyrifos during development.

Carr RL, Armstrong NH, Buchanan AT, Eells JB, Mohammed AN, Ross MK, Nail CA.

Neurotoxicology. 2017 Mar;59:183-190. doi: 10.1016/j.neuro.2015.11.016. Epub 2015 Nov 28.

PMID:
26642910
5.

The cannabinoid receptor antagonist AM251 increases paraoxon and chlorpyrifos oxon toxicity in rats.

Liu J, Pope C.

Neurotoxicology. 2015 Jan;46:12-8. doi: 10.1016/j.neuro.2014.11.001. Epub 2014 Nov 20.

6.

Comparative effects of parathion and chlorpyrifos on extracellular endocannabinoid levels in rat hippocampus: influence on cholinergic toxicity.

Liu J, Parsons L, Pope C.

Toxicol Appl Pharmacol. 2013 Nov 1;272(3):608-15. doi: 10.1016/j.taap.2013.07.025. Epub 2013 Aug 7.

7.

Comparative effects of parathion and chlorpyrifos on endocannabinoid and endocannabinoid-like lipid metabolites in rat striatum.

Liu J, Parsons L, Pope C.

Neurotoxicology. 2015 Sep;50:20-7. doi: 10.1016/j.neuro.2015.07.006. Epub 2015 Jul 26.

8.

Attenuation of anticipatory nausea in a rat model of contextually elicited conditioned gaping by enhancement of the endocannabinoid system.

Limebeer CL, Abdullah RA, Rock EM, Imhof E, Wang K, Lichtman AH, Parker LA.

Psychopharmacology (Berl). 2014 Feb;231(3):603-12. doi: 10.1007/s00213-013-3282-7. Epub 2013 Sep 17.

PMID:
24043345
9.

Dual blockade of FAAH and MAGL identifies behavioral processes regulated by endocannabinoid crosstalk in vivo.

Long JZ, Nomura DK, Vann RE, Walentiny DM, Booker L, Jin X, Burston JJ, Sim-Selley LJ, Lichtman AH, Wiley JL, Cravatt BF.

Proc Natl Acad Sci U S A. 2009 Dec 1;106(48):20270-5. doi: 10.1073/pnas.0909411106. Epub 2009 Nov 16.

10.

Endocannabinoid modulation by FAAH and monoacylglycerol lipase within the analgesic circuitry of the periaqueductal grey.

Lau BK, Drew GM, Mitchell VA, Vaughan CW.

Br J Pharmacol. 2014 Dec;171(23):5225-36. doi: 10.1111/bph.12839. Epub 2014 Sep 5.

11.
12.

Inhibition of monoacylglycerol lipase and fatty acid amide hydrolase by analogues of 2-arachidonoylglycerol.

Ghafouri N, Tiger G, Razdan RK, Mahadevan A, Pertwee RG, Martin BR, Fowler CJ.

Br J Pharmacol. 2004 Nov;143(6):774-84. Epub 2004 Oct 18.

14.

Fatty acid amide hydrolase but not monoacyl glycerol lipase controls cell death induced by the endocannabinoid 2-arachidonoyl glycerol in hepatic cell populations.

Siegmund SV, Wojtalla A, Schlosser M, Zimmer A, Singer MV.

Biochem Biophys Res Commun. 2013 Jul 19;437(1):48-54. doi: 10.1016/j.bbrc.2013.06.033. Epub 2013 Jun 24.

PMID:
23806692
15.

Endocannabinoid contribution to Δ9-tetrahydrocannabinol discrimination in rodents.

Wiley JL, Walentiny DM, Wright MJ Jr, Beardsley PM, Burston JJ, Poklis JL, Lichtman AH, Vann RE.

Eur J Pharmacol. 2014 Aug 15;737:97-105. doi: 10.1016/j.ejphar.2014.05.013. Epub 2014 May 22.

16.

Dual fatty acid amide hydrolase and monoacylglycerol lipase blockade produces THC-like Morris water maze deficits in mice.

Wise LE, Long KA, Abdullah RA, Long JZ, Cravatt BF, Lichtman AH.

ACS Chem Neurosci. 2012 May 16;3(5):369-78. doi: 10.1021/cn200130s. Epub 2012 Jan 27.

17.

Activation of the endocannabinoid system by organophosphorus nerve agents.

Nomura DK, Blankman JL, Simon GM, Fujioka K, Issa RS, Ward AM, Cravatt BF, Casida JE.

Nat Chem Biol. 2008 Jun;4(6):373-8. doi: 10.1038/nchembio.86. Epub 2008 Apr 27.

18.

Discovery and development of endocannabinoid-hydrolyzing enzyme inhibitors.

Minkkilä A, Saario S, Nevalainen T.

Curr Top Med Chem. 2010;10(8):828-58. Review.

PMID:
20370710
19.

Simultaneous inhibition of fatty acid amide hydrolase and monoacylglycerol lipase shares discriminative stimulus effects with Δ9-tetrahydrocannabinol in mice.

Hruba L, Seillier A, Zaki A, Cravatt BF, Lichtman AH, Giuffrida A, McMahon LR.

J Pharmacol Exp Ther. 2015 May;353(2):261-8. doi: 10.1124/jpet.115.222836. Epub 2015 Feb 24.

20.

A comparison of novel, selective fatty acid amide hydrolase (FAAH), monoacyglycerol lipase (MAGL) or dual FAAH/MAGL inhibitors to suppress acute and anticipatory nausea in rat models.

Parker LA, Limebeer CL, Rock EM, Sticht MA, Ward J, Turvey G, Benchama O, Rajarshi G, Wood JT, Alapafuja SO, Makriyannis A.

Psychopharmacology (Berl). 2016 Jun;233(12):2265-75. doi: 10.1007/s00213-016-4277-y. Epub 2016 Apr 6.

PMID:
27048155

Supplemental Content

Support Center